Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2014 Financial Results March 25, 2015
Titan Pharmaceuticals Announces Completion of Enrollment in Phase 3 Study of Probuphine for Opioid Dependence November 20, 2014
Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2014 Financial Results November 7, 2014
